Nasdaq stss.

Find the latest historical data for Sharps Technology Inc. Common Stock (STSS) at Nasdaq.com.

Nasdaq stss. Things To Know About Nasdaq stss.

By Thomas Kerr, CFA NASDAQ:STSS OVERVIEW Sharps Technology, Inc. (NASDAQ:STSS) is a medical device company specializing in drug delivery technology for the pharmaceutical and healthcare markets.NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) — Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, today announced that it has entered into a definitive agreement with institutional investors for …Apr 19, 2022 · Medical device company Sharps Technology (NASDAQ: STSS) is enjoying a massive surge in its share price today following the close of its initial public offering (IPO).STSS stock is up more than 40% ... Sharps Technology stock was originally listed at a price of $2.11 in Apr 14, 2022. If you had invested in Sharps Technology stock at $2.11, your return over the last 1 years would have been -77.73%, for an annualized return of -77.73% (not including any dividends or dividend reinvestments).

The latest price target for Sharps Technology ( NASDAQ: STSS) was reported by Aegis Capital on Tuesday, May 9, 2023. The analyst firm set a price target for 16.00 expecting STSS to rise to within ... Stock analysis for Sharps Technology Inc (STSS:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

WEST COLUMBIA, S.C. and NEW YORK, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Nephron Pharmaceuticals Corporation and Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery company offering patented, best-in-class syringe products, announced today a …NEW YORK, NY - (NewMediaWire) - September 22, 2023 - Sharps Technology, Inc. (NASDAQ: STSS), is pleased to announce its CEO, Robert Hayes, recently conducted an interview with SmallCapsDaily ...

STSS Sharps Technology Inc Sharps Technology Appoints Justin Page as Vice President of Technical Operations NEW YORK, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the 'Company', 'Sharps') (NASDAQ: 'STSS' and 'STSSW'), an innovative medical device and drug delivery Company offering patented, ...Home › NASDAQ: STSS. Medical Instruments & Supplies. STSS. 0.4551. price down ... Market perception of STSS: Favorable market sentiment surrounding STSS, such as ...Find the best open-source package for your project with Snyk Open Source Advisor. Explore over 1 million open source packages.Sep 27, 2023 · NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company ...

Jul 14, 2022 · NEW YORK, July 14, 2022 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device company offering patented, best-in-class ...

Great news for Sharps Technology, Inc. (NASDAQ:STSS): Insiders acquired stock in large numbers last year. Get the latest Sharps Technology, Inc. (STSS) stock news and headlines to help you in your ...

See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. STSS's current price target is $0.00. Learn why top analysts are making this stock forecast for Sharps Technology at MarketBeat.Baosheng Media Group Holdings Limited Ordinary shares (BAOS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.High-Value specialized prefillable syringe systems to accelerate revenue growth in 2023 and beyond. Company to launch next generation specialty polymer-based syringe products for the healthcare marketSharps Technology stock was originally listed at a price of $2.11 in Apr 14, 2022. If you had invested in Sharps Technology stock at $2.11, your return over the last 1 years would have been -77.73%, for an annualized return of -77.73% (not including any dividends or dividend reinvestments).Jan 30, 2023 · By Thomas Kerr, CFA NASDAQ:STSS OVERVIEW Sharps Technology, Inc. (NASDAQ:STSS) is a medical device company specializing in drug delivery technology for the pharmaceutical and healthcare markets. The company operates two primary syringe-based platforms which includes pre-filled syringes and smart safety syringes. In November 2022, Sharps entered into an impactful manufacturing and research Jan 13, 2023 · NASDAQ, Inc. short interest is available by issuer for the past 12 months and updated twice a month. Short interest data is reported on mid-month and end-of-month settlement dates. It is then ...

NEW YORK, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company ...Dec 1, 2023 · Is Sharps Technology (NASDAQ:STSS) the best stock in the Surgical & medical instruments industry? Compare top STSS competitors at MarketBeat. Stock Screener Earnings Calendar Sectors Nasdaq | STSS U.S.: Nasdaq Sharps Technology Inc. Watch list NEW Set a price target alert After Hours Last Updated: Oct 26, 2023 6:44 p.m. EDT Delayed... 05.04.2023 - ORLANDO, FL / ACCESSWIRE / April 5, 2023 / RedChip Companies will air new interviews with BullFrog AI (NASDAQ:BFRG) and Sharps Technology (NASDAQ:STSS) on The RedChip Money Report ...NEW YORK, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company ...

STSS Sharps Technology Inc Form 8-K - Current report. Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of ...

... Technology Inc (STSS). Sharps Technology Inc (STSS). 0.4700 +0.0002 (+0.04%) 12/01/23 [NASDAQ]. N/A x N/A N/A x N/A. Realtime by (Cboe BZX). N/A x N/A N/A x N/A.NEW YORK, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company ...Contact Us U.S. markets closed -0.50 Dow Futures +10.00(+0.03%) (-0.09%) Russell 2000 Futures +0.90(+0.05%) Crude Oil +0.15(+0.20%) Gold 2,014.20 (+0.09%) Sharps …Nov 16, 2023 · Nephron Pharmaceuticals Corporation and Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery company offering patented, best-in-class syringe products, announced today a new partnership focused on developing and sharing best practices in innovative manufacturing, product development, customer support, and quality as ... Feb 9, 2023 · STSS Sharps Technology Inc Sharps Technology Appoints Justin Page as Vice President of Technical Operations NEW YORK, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the 'Company', 'Sharps') (NASDAQ: 'STSS' and 'STSSW'), an innovative medical device and drug delivery Company offering patented, ... At Cannae Holdings, a filing with the SEC revealed that on Monday, Director Barry B. Moullet bought 1,000 shares of CNNE, for a cost of $23.06 each, for a total investment of $23,064. So far ...NEW YORK, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company ...May 9, 2023 · The firm decreased its portfolio allocation in STSS by 64.58% over the last quarter. Empery Asset Management holds 830K shares representing 7.12% ownership of the company. No change in the last ... Sharps Technology Inc. Common Stock (STSS) Advanced Charting - Nasdaq offers advanced charting & market activity data for US and global markets.Sharps Technology Inc. Common Stock (STSS) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets.

STSS Sharps Technology Inc Form 8-K - Current report. Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of ...

According to NASDAQ, as of May 2014, the highest NASDAQ closing ever was achieved on March 9, 2000, when the market closed at a record 5046.86. USA Today reports that the highest closing achieved by NASDAQ since was a 4007.09 closing on Nov...

Stock Screener Earnings Calendar Sectors Nasdaq | STSS U.S.: Nasdaq Sharps Technology Inc. Watch list NEW Set a price target alert After Hours Last Updated: Oct 26, 2023 6:44 p.m. EDT Delayed...Find the latest Revenue & EPS data for Sharps Technology Inc. Common Stock (STSS) at Nasdaq.com.Sharps Technology has extensive expertise in specialized prefilled syringe systems and ready to use processing. The company has a manufacturing facility in Hungary and has partnered with Nephron ...STSS Sharps Technology Inc Form S-3 - Registration statement under Securities Act of 1933. As filed with the Securities and Exchange Commission on August 22, 2023, Registration Statement No. 333 ...US82003F1012. Sharps Technology, Inc. is a medical device and pharmaceutical packaging company, which engages in the development and manufacturing of innovative drug delivery systems. It also focuses on low waste, and ultra-low waste syringe technologies that incorporate both passive and active safety features. NEW YORK, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company ...BullFrog AI Strengthens Capabilities of its AI Platform through Expansion of Licensing Agreement with Johns Hopkins Applied Physics Laboratory. GAITHERSBURG, Md., June 05, 2023 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) ("BullFrog AI" or the "Company"), a digital technology company using machine …The common stock and warrants began trading on The Nasdaq Capital Market on April 14, 2022, under the symbols “STSS” and “STSSW,” respectively. Aegis Capital Corp. acted as the sole book ...STSS Sharps Technology Inc Statement of Changes in Beneficial Ownership (4) FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.NEW YORK, July 06, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company offering ...NEW YORK, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company ...ORLANDO, FL / ACCESSWIRE / September 29, 2023 / RedChip Companies will air interviews with Sharps Technology, Inc. (NASDAQ:STSS), Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) and American ...

Robert Hayes, CEO of Sharps Technology, Inc. (NASDAQ: STSS), delves into what Sharps does, what exciting developments have transpired such as their major dis...STSS Sharps Technology Inc Form 4 - Statement of changes in beneficial ownership of securities. SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF ...Shares of Sharps Technology, Inc. (NASDAQ:STSS) were down 35% to $0.5301 after the company reported a $5.6 million registered direct and private placement priced at the market under Nasdaq rules. ...Instagram:https://instagram. vertex pharma stockt dividend record datearthur j. gallagheprice of silver kennedy half dollars Find the latest analyst research for Sharps Technology Inc. Common Stock (STSS) at Nasdaq.com.Nephron Pharmaceuticals Corporation and Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery company offering patented, best-in-class syringe products, announced today a new partnership focused on developing and sharing best practices in innovative manufacturing, product development, customer support, and quality as ... parg stock forecastcoinbase alternative NEW YORK, June 08, 2022 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), is an innovative medical device company offering patented, best-in ... bond brokers NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company ...WEST COLUMBIA, S.C. and NEW YORK, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Nephron Pharmaceuticals Corporation and Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an ...